Listed by the USPTO as LEE, HOI YAN NMN
Tech Center 1700 • Art Units: 1623 1693 1759
This examiner grants 38% of resolved cases
LEE, HOI YAN NMN has 88 resolved cases and a 37.5% allowance rate. The interview lift is 76.2%, and the median time to allowance is 1255 days. The profile is associated with Tech Center 1700 and Art Unit 1623. The interview lift is the strongest feature of the reported record, indicating that interviews may be especially important when addressing claim issues. The 37.5% allowance rate and 1255-day median also support careful planning for persistence and timing.
The listed companies are The Brigham and Women's Hospital Inc., CJ CheilJedang Corporation, and IFP Energies nouvelles. The leading firms are Ipsilon USA - NLO, Leason Ellis LLP, and Baker Botts L.L.P. This applicant mix gives practitioners context for the biotechnology and chemical matters represented in the docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17297586 | D-PSICOSE CRYSTAL AND PREPARATION METHOD THEREFOR | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17621987 | LIQUID PHASE SEPARATION OF 2G SUGARS BY ADSORPTION ON A FAU ZEOLITE HAVING A SI/AL ATOMIC RATIO GREATER THAN 1.5 | Final Rejection | IFP Energies nouvelles |
| 18695914 | DERIVATIVES FROM 2,5,6-TRIMETHYLCYCLOHEX-2-EN-1-OL AS AROMA INGREDIENTS | Non-Final OA | BASF SE |
| 18334457 | LIQUID COMPOSITION | Final Rejection | Shin-Etsu Chemical Co., Ltd. |
| 17606441 | STABILIZATION AND PRESERVATION OF IN VITRO TRANSCRIPTION REACTIONS | Final Rejection | President and Fellows of Harvard College |
| 17283728 | ENZYMATIC RNA SYNTHESIS | Non-Final OA | President and Fellows of Harvard College |
| 17995264 | PREPARATION FOR USE AS VASORELAXANT | Non-Final OA | Evonik Operations GmbH |
| 18708483 | ANTIVIRAL AGENT | Non-Final OA | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY |
| 17293632 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | Final Rejection | VERTEX PHARMACEUTICALS INCORPORATED |
| 19003429 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES WITH DIABETES | Non-Final OA | ARIBIO CO., LTD. |
| 17580129 | METHODS TO PREVENT, INHIBIT OR TREAT INTERVERTEBRAL DISC DEGENERATION | Final Rejection | University of Iowa Research Foundation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy37.5% of resolved applications examined by Hoi Yan Nmn Lee were allowed (88 resolved cases), compared with 51.3% across Art Unit 1623 over the last five years.
This examiner's interview lift is +76.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Hoi Yan Nmn Lee took 1,255 days on average from filing to allowance.
Hoi Yan Nmn Lee examines applications in Art Unit 1623 in Tech Center 1700 (Chemistry & Materials).
